Prosperia, the Mexican startup that offers B2B services for pre-diagnosis through artificial intelligence (AI) to prevent illnesses caused by chronic diseases, raised $2 million in a seed round.
This was financed by the new Swedish fund focused on healthcare companies, Cardo Health, Cristina Campero, CEO and co-founder of this healthTech, told Contxto.
Two and a half years after starting operations and offering free services for a year as a pilot, Prosperia has already raised around US$2.25 million. With the new capital, the company will seek to double its growth by 2022, perform 10,000 pre-evaluations per month (a figure previously achieved in one year), and have a presence throughout the country.
The company is working in Mexico with companies such as Devlin (an optical eyewear company), which already concentrate on a population at risk of developing some ophthalmological pathology due to diabetes or hypertension, and people over 60 years of age.
The healthTech has two products: a risk calculator, which are intelligent questionnaires that patients can fill out online only. It determines the person’s risk of developing diabetes, hypertension, or an ophthalmological condition.
The other product is an eye health assessment.
It is done using a fundus camera that allows a picture of the retina to be taken without any discomfort.
The digital images are analyzed on the platform with Prosperia’s AI algorithms, which recognize possible damage.
Currently, the startup offers its services in more than 100 locations in Mexico City. Among its largest clients are Devlin, Diabesmart, Laboratorios Similares and Oftalmología Salauno.
